An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis
Overview
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis
Full Title of Study: “An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: October 2009
Interventions
- Drug: C-KAD Ophthalmic Solution
- 4 drops applied daily for 180 days
Arms, Groups and Cohorts
- Experimental: C-KAD Ophthalmic Solution
Clinical Trial Outcome Measures
Primary Measures
- Reduction in the number of asteroid bodies
- Time Frame: 180
Participating in This Clinical Trial
Inclusion Criteria
- Presence of asteroid hyalosis Exclusion Criteria:
- Active ocular infection – Glaucoma – Ocular hypertension – Ocular inflammatory disorders
Gender Eligibility: All
Minimum Age: 21 Years
Maximum Age: 90 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Chakshu Research, Inc.
- Provider of Information About this Clinical Study
- Ellen Hoogeveen /Associate Director, Clinical & Regulatory Affairs, Chakshu Research, Inc.
- Overall Official(s)
- Ira Wong, MD, Study Director, Chakshu Research, Inc.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.